Loading clinical trials...
Loading clinical trials...
Predictive Value of the Contrast Media Volume to Creatinine Clearance Ratio for the Risk of Contrast-Induced Nephropathy After Coronary Angiography
Conditions
Locations
1
China
Guangdong Cardiovascular Institute,Guangdong General Hospital
Guangzhou, Guangdong, China
Start Date
December 1, 2010
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
September 16, 2014
NCT04982419
NCT01402232
NCT03121053
NCT01976299
NCT01144091
NCT00312117
Lead Sponsor
Guangdong Provincial People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions